A. Tricas

Dolutegravir monotherapy in HIV-infected patients with sustained viral suppression.

J. Gatell, J. Mallolas, E. Martinez, 2016, The Journal of antimicrobial chemotherapy.

Dolutegravir-based maintenance monotherapy versus dual therapy with lamivudine: a planned 24 week analysis of the DOLAM randomized clinical trial

Roger Paredes, Esteban Martinez, Bonaventura Clotet, 2018, The Journal of antimicrobial chemotherapy.

A maintenance 3-day-per-week schedule with the single tablet regimen efavirenz/emtricitabine/tenofovir disoproxil fumarate is effective and decreases sub-clinical toxicity

M. Plana, J. Miro, J. Gatell, 2018, AIDS.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Tolerability of integrase inhibitors in a real-life setting

J. Gatell, J. Blanch, J. Mallolas, 2017, The Journal of antimicrobial chemotherapy.

A 24-week pilot study of dual maintenance therapy with raltegravir plus lamivudine.

M. Plana, J. Blanch, J. Mallolas, 2019, AIDS.

Unintended HIV-1 Infection During Analytical Therapy Interruption.

L. Leal, C. Casado, C. López-Galíndez, 2019, The Journal of infectious diseases.